Strategic Growth PaceMate is a market-leading, tech-enabled cardiac device monitoring platform with national reach across integrated delivery networks and academic health systems, suggesting expanding footprint opportunities with large hospital networks and new health systems.

Data Advantage Backed by a research-grade cardiac dataset integrating discrete device, EHR, and operational data, PaceMate presents a compelling upsell path for customers seeking advanced analytics, population health insights, and decision support across cardiology care workflows.

Leadership Signals Recent executive hires in Chief Medical Officer and Head of AI, Innovation and Data Strategy indicate a sharpened focus on clinical excellence and AI-driven solutions, opening conversations around clinical outcomes, AI-enabled monitoring, and evidence-driven implementations.

Acquisition Momentum Strategic acquisition of Medtronic workflow tech in 2024 positions PaceMate as a consolidator in the cardiac monitoring space, creating cross-sell opportunities with legacy Medtronic customers and momentum for expanded device and EHR integrations.

Platform Expansion Launch of PaceMateLIVE and the PaceArt data migration tools signals a transition to scalable, cloud-based data management, presenting opportunities to migrate existing customers, modernize their workflows, and consolidate multiple data sources under one platform.